Africa Corporate Wellness Market, by End User, 2018-2027
| Label | Neurogenerative Disorder | Fibromyalgia | Diabetes | Protein Bars | Energy Drinks | Others |
|---|---|---|---|---|---|---|
| 2018 | 15.64 USD Mn | 8.88 USD Mn | 1.54 USD Mn | 5.26 USD Mn | 2.72 USD Mn | 46.06 USD Mn |
| 2019 | 28.99 USD Mn | 17.75 USD Mn | 3.04 USD Mn | 10.18 USD Mn | 5.32 USD Mn | 85.74 USD Mn |
| 2020 | 54.03 USD Mn | 35.53 USD Mn | 6.01 USD Mn | 19.78 USD Mn | 10.47 USD Mn | 160.49 USD Mn |
| 2021 | 100.92 USD Mn | 71.46 USD Mn | 11.94 USD Mn | 38.54 USD Mn | 20.66 USD Mn | 300.29 USD Mn |
| 2022 | 189.8 USD Mn | 143.05 USD Mn | 23.7 USD Mn | 75.51 USD Mn | 40.85 USD Mn | 568.97 USD Mn |
| 2023 | 358.79 USD Mn | 287.87 USD Mn | 47.31 USD Mn | 148.69 USD Mn | 81.19 USD Mn | 1082.68 USD Mn |
| 2024 | 680.95 USD Mn | 581.56 USD Mn | 94.8 USD Mn | 293.96 USD Mn | 162.01 USD Mn | 2066.33 USD Mn |
| 2025 | 1296.18 USD Mn | 1178.38 USD Mn | 190.53 USD Mn | 582.87 USD Mn | 324.23 USD Mn | 3951.19 USD Mn |
| 2026 | 2479.01 USD Mn | 2399 USD Mn | 384.75 USD Mn | 1161.23 USD Mn | 651.96 USD Mn | 7582.8 USD Mn |
| 2027 | 4851.11 USD Mn | 4997.23 USD Mn | 794.95 USD Mn | 2367.11 USD Mn | 1341.36 USD Mn | 14871.8 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The Pacific Cannabidiol (CBD) Market,By Application portion of the Asia market is on a steady long-term growth path. Segment value stands at roughly USD 14659 Mn in 2026 and is projected to reach USD 29224 Mn by 2027 — a gain of about 99% over the forecast period, translating to a CAGR in the double digits.
- What the regional split looks like (2026): Others leads, holding roughly 52% of segment value — the single largest regional share. Neurogenerative Disorder is the second-largest contributor. Fibromyalgia, Protein Bars, Energy Drinks and Diabetes make up the remainder, in descending order.
- By 2027, Others alone is expected to reach USD 14872 Mn, with Fibromyalgia at USD 4997 Mn.
Market Dynamics
Asia-Pacific is emerging as one of the fastest-growing markets for cannabidiol (CBD). CBD is a naturally occurring compound found in the cannabis plant and has gained significant attention for its potential therapeutic benefits. It is widely used for medical purposes, such as pain relief, anxiety treatment, and management of various health conditions.
The Asia-Pacific CBD market is segmented by application, including pharmaceuticals, food and beverage, cosmetics and personal care, and others. The pharmaceutical segment dominates the market as CBD is used in the treatment of various disorders such as epilepsy, Parkinson's disease, and anxiety. With the increasing prevalence of chronic diseases and mental health disorders in the region, the demand for CBD as a therapeutic agent is expected to grow.
The food and beverage segment is also experiencing a significant demand for CBD, especially in countries like China, Japan, and South Korea. CBD-infused products such as energy drinks, chocolates, and oils have gained popularity among consumers for their potential health benefits. Moreover, the growing trend of natural and organic products is further driving the demand for CBD in the food and beverage industry.
The cosmetics and personal care segment is another rapidly expanding application for CBD in the Asia-Pacific market. CBD is known for its anti-inflammatory and antioxidant properties, making it a popular ingredient in skincare and beauty products. In countries like South Korea and Japan, where there is a high demand for skincare and beauty products, the market for CBD-infused cosmetics is expected to witness significant growth.
Besides these key applications, CBD is also used in other industries such as textiles, paper, and construction. The growing awareness of the environmentally-friendly and sustainable properties of hemp-derived CBD is expected to drive its demand in these industries.
Asia-Pacific is home to some of the largest cannabis cultivators in the world, such as China, India, and Thailand, which makes it a significant player in the global CBD market. The region's population also plays a crucial role in driving the demand for CBD-based products. As per the World Bank, the population of the Asia-Pacific region is expected to reach 4.64 billion by 2050, which presents a huge potential consumer base for CBD products.
The increasing awareness about CBD's therapeutic benefits, favorable government regulations, and growing investment in the cannabis industry are some of the key factors driving the demand for CBD in the Asia-Pacific region. As more countries in the region legalize the use of CBD, the market is expected to witness significant growth in the coming years.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



